Skip to main content

Month: June 2024

Oil-Dri Announces Record Sales and Gross Profit for the Third Quarter and First Nine-Months of Fiscal 2024

CHICAGO, June 06, 2024 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its third quarter and first nine-months of fiscal year 2024.  Third Quarter Year to Date(in thousands, except per share amounts) Ended April 30, Ended April 30,  2024 2023 Change 2024 2023 ChangeConsolidated Results            Net Sales $ 106,779 $ 105,425 1% $ 323,885 $ 305,633 6%Net Income Attributable to Oil-Dri $ 7,777 $ 8,535 (9)% $ 30,901 $ 17,632 75%Net Income Attributable to Oil-Dri Excluding Nonrecurring Events † $ 7,777 $ 13,319 (42)% $ 31,363 $ 24,393 29%Diluted EPS – Common $ 1.07 $ 1.24 (14)% $ 4.26 $ 2.58 65%Diluted EPS – Common, Excluding Nonrecurring Events † $ 1.07 $ 1.94 (45)% $ 4.32 $ 3.57 21%Business to...

Continue reading

XPO Provides North American LTL Operating Data for May 2024

GREENWICH, Conn., June 06, 2024 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for May 2024. LTL tonnage per day increased 2.4%, as compared with May 2023, attributable to a year-over-year increase of 3.8% in shipments per day and a decrease of 1.4% in weight per shipment. Actual results for May 2024 may vary from the preliminary results reported above. Mario Harik, chief executive officer of XPO, said, “We’re continuing to take profitable share in a soft freight market, with improved service quality driving consistent above-market yield growth. Through May, our second quarter yield ex-fuel is tracking to a sequential improvement from the first quarter.”  Harik continued, “Providing world class service to our customers...

Continue reading

Zumiez Inc. Announces Fiscal 2024 First Quarter Results

Board Approves New Stock Repurchase Authorization LYNNWOOD, Wash., June 06, 2024 (GLOBE NEWSWIRE) — Zumiez Inc. (NASDAQ: ZUMZ), a leading specialty retailer of apparel, footwear, equipment and accessories for young men and women, today reported results for the first quarter ended May 4, 2024. Net sales for the first quarter ended May 4, 2024 (13 weeks) decreased 3.0% to $177.4 million from $182.9 million in the first quarter ended April 29, 2023 (13 weeks). Net loss in the first quarter of fiscal 2024 was $16.8 million, or $0.86 loss per diluted share, compared to a net loss of $18.4 million, or $0.96 loss per diluted share, in the first quarter of the prior fiscal year. At May 4, 2024, the Company had cash and current marketable securities of $146.6 million compared to cash and current marketable securities of $155.3 million at...

Continue reading

Concrete Pumping Holdings Reports Second Quarter Fiscal Year 2024 Results

DENVER, June 06, 2024 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the second quarter ended April 30, 2024. Second Quarter Fiscal Year 2024 Summary vs. Second Quarter of Fiscal Year 2023 (unless otherwise noted)  ● Revenue of $107.1 million compared to $107.8 million.  ● Gross profit of $41.8 million compared to $43.5 million.  ● Income from operations of $12.1 million compared to $13.2 million.  ● Net income of $3.0 million compared to $5.6 million.  ● Net income attributable to common shareholders of $2.6 million or $0.05 per diluted share, compared to $5.2 million or $0.09 per diluted share.  ● Adjusted EBITDA1 of $27.5...

Continue reading

Mission Produce™ Announces Fiscal 2024 Second Quarter Financial Results

Achieves record second quarter results driven by higher price and volume in the Marketing & Distribution segment OXNARD, Calif., June 06, 2024 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today reported its financial results for the fiscal second quarter ended April 30, 2024. Fiscal Second Quarter 2024 Financial Overview:Total revenue increased 35% to $297.6 million compared to the same period last year driven primarily by a 22% increase in average per-unit avocado selling prices and 8% increase in avocado volume sold Net income of $7.0 million, or $0.10 per diluted share, compared to a net loss of $(4.6) million, or $(0.07) per diluted share, for the same...

Continue reading

Rent the Runway, Inc. Announces First Quarter 2024 Results

Exceeded Revenue and Adjusted EBITDA Guidance for Q1 2024. Improved Business Momentum in Q1 2024. Record Low Quarterly Cash Consumption in Q1 2024. Reiterates Expectation for Revenue Growth and Free Cash Flow Breakeven in FY 2024. NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) — Rent the Runway, Inc. (“Rent the Runway” or “RTR”) (NASDAQ: RENT), the world’s first and largest shared designer closet platform, today reported financial results for the fiscal quarter ended April 30, 2024. Fiscal First Quarter and Recent Business HighlightsRecord low quarterly free cash flow consumption of less than $2M, which is $11M lower than Q1 2023 and $27M lower than Q1 2022. We are reiterating our guidance to be free cash flow breakeven this year. Strong retention rates fueled by enhanced inventory and product experiences and new lifecycle...

Continue reading

Nokia Corporation: Repurchase of own shares on 06.06.2024

Nokia CorporationStock Exchange Release06 June 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.06.2024 Espoo, Finland – On 06 June 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 361,797 3.62CEUX – –BATE – –AQEU – –TQEX – –Total 361,797 3.62* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, today announced TVGN 489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocytes (CTLs) immunotherapy for treatment of COVID-19 in high-risk patients and Long COVID, retains activity against the currently dominant and highly mutated FLiRT strains of SARS-CoV-2 based on a review of this variant’s protein sequences. Named FLiRT to reflect amino acid changes occurring in the spike protein, these Omicron subvariants are descendent from JN.1, the previously dominant strain in the US. TVGN 489 contains Cytotoxic T lymphocytes that recognize...

Continue reading

TRILLION ENERGY ANNOUNCES INCREASE OF NON-BROKERED PRIVATE PLACEMENT AND FIRST AND SECOND TRANCHE CLOSINGS

Vancouver, B.C. , June 06, 2024 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company“) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) wishes to provide an update to its previously announced non- brokered private placement. Further to the Company’s news release dated May 27, 2024 and due to high investor interest, the Company is upsizing the private placement from 20,000,000 units to 30,000,000 units (the “Units“) at a price of $0.09 per Unit, for aggregate gross proceeds of up to a maximum of $2,700,000 (the “Offering“). Each Unit is comprised of one common share of the Company (“Common Share“) and one share purchase warrant (“Warrant“), with each Warrant exercisable at a price of $0.18 per share for a period of two years from...

Continue reading

Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Gout is a painful arthritic disorder affecting an estimated 9.2 million people in the United States1. As gout cases increase every year, treatment requirements increase. The gout treatment market is projected to be $2.0 billion in the U.S. by 2028 with a well-defined area of unmet need.2 Over 70% of gout patients have comorbid conditions that may require dose adjustments and such patients could be a potential target population for Gloperba®3 Over 17% of gout patients on colchicine experienced severe gastrointestinal side effects like diarrhea. These patients may benefit from flexible dosing offered by Gloperba®4 Scilex is well-positioned to market and distribute its third commercial non-opioid...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.